Paricalcitol in hemodialysis patients with secondary hyperparathyroidism and its potential benefits

Table 1 Dose adjustment criteria for paricalcitol injection

iPTH level compared with baseline	Dose adjustment of paricalcitol
Not reaching the standard, unchanged or increased; or decreased by < 30%	Increase dose by 2-4 μg
When 150-300 pg/mL or iPTH down by ≥ 30%	Maintain original dose
When iPTH < 150 pg/mL or serum Ca > 11.0 mg/mL or Ca × P product > 70 mg2/dL2	Decrease dose by 2-4 μg

Ca: Calcium; iPTH: Intact parathyroid hormone; P: Phosphate.